Company Description
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.
Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners.
The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system.
It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, New Zealand, and internationally.
The company was founded in 2014 and is based in Guilford, Connecticut.
| Country | United States |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 111 |
| CEO | Maria Sainz |
Contact Details
Address: 351 New Whitfield Street Guilford, Connecticut 06437 United States | |
| Phone | 866 796 6767 |
| Website | hyperfine.io |
Stock Details
| Ticker Symbol | HYPR |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001833769 |
| CUSIP Number | 44916K106 |
| ISIN Number | US44916K1060 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Maria Sainz | Chief Executive Officer, President and Director |
| R. Scott Huennekens CPA, M.B.A. | Executive Chairman |
| Dr. Jonathan M. Rothberg Ph.D. | Founder and Vice Chairman |
| Brett Hale | Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer and Corporate Secretary |
| Dr. Thomas Teisseyre Ph.D. | Chief Operating Officer |
| Rafael O'Halloran | Vice President of Technology |
| Chip Truwit FACR, M.D. | Senior Vice President of Office Strategy and Partnerships |
| Edmond Knopp M.D. | Chief Medical Officer |
| Rafael Donnay | Senior Vice President of Hospital Strategy and Health Economics |
| Rob Fasciano | Chief Regulatory and Quality Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 2, 2025 | 8-K | Current Report |
| Apr 7, 2025 | ARS | Filing |
| Apr 7, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 7, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 17, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 17, 2025 | 10-K | Annual Report |
| Mar 17, 2025 | 8-K | Current Report |
| Feb 11, 2025 | 8-K | Current Report |
| Feb 11, 2025 | 424B5 | Filing |
| Feb 11, 2025 | 8-K | Current Report |